openPR Logo
Press release

Breast cancer liquid biopsy Market 2018: MDxHealth, QIAGEN, GUARDANT HEALTH, Roche, Menarini Silicon Biosystems., Thermo Fisher Scientific, Biocept, Trovagene, Bio-Rad Laboratories, RainDance Technologies, Myriad Genetics, Fluxion Biosciences,

09-21-2018 06:52 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

/ PR Agency: Data Bridge Market Research
Global Breast Cancer Liquid Biopsy Market

Global Breast Cancer Liquid Biopsy Market

Breast Cancer Liquid Biopsy market report will help the buyer in reviewing the Membrane Filter industry development trends and opportunities. To begin with the Breast Cancer Liquid Biopsy Market report 2018 which covers market characteristics, industry structure and competitive landscape, the problems, desire concepts, along with business strategies market effectiveness. The current trends will determine what options will be for strategical investment. The Breast Cancer Liquid Biopsy Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization. The study provides forecast and estimates market for each product in terms of revenue and volume during the forecast period.

Global Breast Cancer Liquid Biopsy Market is expected to reach USD 761.73 million by 2025, from USD 145.4 million in 2017 growing at a CAGR of 23.0% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Get Free Sample of Report At https://databridgemarketresearch.com/request-a-sample/?dbmr=global-breast-cancer-liquid-biopsy-market

Global Breast Cancer Liquid Biopsy Market By Product (Consumables, Kits), Circulating Biomarkers (Extracellular Vesicles (EVs), Cell-free DNA (cfDNA), ctRNA, Circulating Tumor Cells (CTCs), cfRNA), End Users (Laboratories, Hospitals , Physician Laboratories, Public Health Laboratories, Research Institutes, Small Molecular Laboratories, Pathology Laboratories), Geography (South America, North America, Europe, Middle East & Africa, Asia-Pacific) – Industry Trends and Forecast to 2025

Competitors/Players: Global Breast Cancer Liquid Biopsy Market

• MDxHealth,
• QIAGEN,
• GUARDANT HEALTH, INC,
• Janssen Global Services, LLC,
• F. Hoffmann-La Roche Ltd,
• Menarini Silicon Biosystems.,
• Thermo Fisher Scientific Inc,
• Biocept, Inc,
• Trovagene,
• Bio-Rad Laboratories, Inc.,
• RainDance Technologies, Inc.,
• Myriad Genetics, Inc,
• Fluxion Biosciences, Inc.,
• Isogen Life Science B.V.,
• Cynvenio Biosystems, Inc.
• Guardant Health, Inc.,
• Biodesix, Inc,
• Genomic Health,
• FOUNDATION MEDICINE, INC,
• Sysmex Corporation,
• Exosome Diagnostics,
• NeoGenomics Laboratories,
• among others.

Table of Contents

1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
8. Delivery
9. Industry Type
10. Geography
10.1. Overview
10.2. North America
10.3. Europe
10.4. Asia-Pacific
10.5. South America
10.6. Middle East & Africa
11. Company Landscape
12. Company Profiles
13. Related Reports

Request for Detailed TOC: https://databridgemarketresearch.com/toc/?dbmr=global-breast-cancer-liquid-biopsy-market

Competitive Analysis: Global Breast Cancer Liquid Biopsy Market

The Global Breast Cancer Liquid Biopsy Market is highly fragmented and the major players have used various strategies such product launches, technology developments, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Continuous Manufacturing market for global, Europe, North America, Asia Pacific and South America.

In August 17, 2017, Cynvenio Biosystems, Inc. (WESTLAKE VILLAGE, CA), launched new breast cancer monitoring study in business with Saint Luke’s Cancer Institute in Kansas City, Missouri.

Major Market Drivers and Restraints:

• Rising applications of liquid biopsy.

• Rising geriatric population along with cancer incidences.

• Increasing focuses on R&D in medical field for cancers.

• Clinical utility challenges towards liquid biopsy.

Key Developments in the Market:

• In August 2017, Cynvenio Biosystems, Inc. (WESTLAKE VILLAGE) launched its second generation PD-L1 expression test. This new blood test offers improved analytic performance as compare to first generation PD-L1 test and has high sensitivity, specific profiling and monitoring of PD-L1 expression on lung cancer cells recovered from a simple blood draw.

• In May 2017, Cynvenio Biosystems Inc. (Westlake Village, Calif), released ClearID Total Insight Breast Cancer which is a liquid biopsy monitoring service for patients to treat cancer related problems.
Primary Respondents

• Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

• Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others

Reasons to Purchase this Report:

• Current and future of global breast cancer liquid biopsy market outlook in the developed and emerging markets

• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

• Regions/countries that are expected to witness the fastest growth rates during the forecast period

• The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

• All segmentation provided above in this report is represented at country level

• All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization).

Speak To Industry Experts Request Analyst Call At https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-breast-cancer-liquid-biopsy-market

Market Segmentation: Global Breast Cancer Liquid Biopsy Market

The global breast cancer liquid biopsy market is segmented based on

• product,
• circulating biomarkers,
• end user and
• geographical segments.

Based on product type, the market is segmented into

• consumables
• kits

On the basis of circulating biomarkers, the market is segmented into

• Extracellular Vesicles (EVs),
• Cell-free DNA (cfDNA),
• ctRNA,
• Circulating Tumor Cells (CTCs)
• cfRNA.

On the basis of end users, the market is segmented into

• laboratories,
• hospitals,
• physician laboratories,
• public health laboratories,
• research institutes,
• small molecular laboratories
• pathology laboratories

Based on geography, the market report covers data points for 28 countries across multiple geographies namely

• North America & South America,
• Europe,
• Asia-Pacific and,
• Middle East & Africa.

Note: If You Have Any Special Requirements, Please Let Us Know And We Will Offer You The Report As You Want.

Customization and Discount On This Report at https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-breast-cancer-liquid-biopsy-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavorsto provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Breast cancer liquid biopsy Market 2018: MDxHealth, QIAGEN, GUARDANT HEALTH, Roche, Menarini Silicon Biosystems., Thermo Fisher Scientific, Biocept, Trovagene, Bio-Rad Laboratories, RainDance Technologies, Myriad Genetics, Fluxion Biosciences, here

News-ID: 1255971 • Views:

More Releases from Data Bridge Market Research

Vitamin K Market IS growing at a CAGR of 6.8% during the forecast period of 2023 to 2030
Vitamin K Market IS growing at a CAGR of 6.8% during the forecast period of 2023 …
Vitamin K Market Analysis and Size The essential factors contributing to the growth of the market in the forecast period of 2023 to 2020 include growing demand for vitamin supplements, changing dietary patterns, and rising health consciousness. Data Bridge Market Research analyses that the global vitamin K market, which was USD 841.47 million in 2022, is expected to reach USD 1,410.20 million by 2030, growing at a CAGR of 6.8% during the
Transformer Oil Market is expected to undergo a CAGR of 7.55% by 2029
Transformer Oil Market is expected to undergo a CAGR of 7.55% by 2029
Transformer Oil Market Analysis and Size Transformers are almost everywhere, and every power and distribution transformer is filled with the dielectric insulating fluid, which consists high resistance to electricity and cools the transformer. The "bio based oil" is the highest growing type segment because it has better resistance to fire as compared to other oil over the forecast period. Furthermore, the growth of electric grids in developing economies and the upgradation
 Fatty Alcohols Market is expected to undergo a CAGR of 5.15% by 2029
 Fatty Alcohols Market is expected to undergo a CAGR of 5.15% by 2029
Fatty Alcohols Market Analysis and Size The rising demand of hygiene product coupled with growing consumer awareness is anticipated to drive the personal care industry and boost the growth of the fatty alcohols market. Fatty alcohols are used as emollients, emulsifiers and catalytic hydrogenation in cosmetics and beauty products. The "C11-C14 fatty alcohols" is the fastest growing product segment because it is used to produce sodium laureth ether sulphate (SLES), a major foaming agent
Exclusive Insights on Gusseted Bags Market Latest Trends, Drivers, Strategies and Competitive Landscape Top Players Analysis Industry Trends and Forecast
Exclusive Insights on Gusseted Bags Market Latest Trends, Drivers, Strategies an …
An important Gusseted Bags Market research report is produced by taking into account every requirement that organizations need to meet in order to expand successfully. This market report forecasts the market size based on data on major retailer sales, industry growth by upstream and downstream factors, industry advancement, major players, market segments, and application. When creating the reliable Gusseted Bags Market study, the goals of the marketing research are taken into

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top